Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gilda Denise Zielinski"'
Autor:
Gilda Denise Zielinski, Nienke vanRein, Martina Teichert, Frederikus A. Klok, Frits R. Rosendaal, Felix J. M. van derMeer, Menno V. Huisman, Suzanne C. Cannegieter, Willem M. Lijfering
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 1, Pp 141-153 (2020)
Abstract Background In contrast to vitamin K antagonists (VKA), direct oral anticoagulants (DOAC's) are not strictly monitored and dose titrated by anticoagulation clinics in the Netherlands. This may affect drug persistence of atrial fibrillation (A
Externí odkaz:
https://doaj.org/article/1d1f8cadf9954cbc8c400b71defeab7b
Autor:
Willem M. Lijfering, Gilda Denise Zielinski, Menno V. Huisman, Suzanne C. Cannegieter, Frits R. Rosendaal, Nienke van Rein, Frederikus A. Klok, Felix J. M. van der Meer, Martina Teichert
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 1, Pp 141-153 (2020)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, 4(1), 141-153. WILEY
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, 4(1), 141-153. WILEY
Background In contrast to vitamin K antagonists (VKA), direct oral anticoagulants (DOAC's) are not strictly monitored and dose titrated by anticoagulation clinics in the Netherlands. This may affect drug persistence of atrial fibrillation (AF) patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c96089344c7ec9c2bff91cd46339565
https://doi.org/10.1002/rth2.12261
https://doi.org/10.1002/rth2.12261
Autor:
Martina Teichert, Willem M. Lijfering, Gilda Denise Zielinski, Frits R. Rosendaal, Felix J. M. van der Meer, Frederikus A. Klok, Nienke van Rein, Suzanne C. Cannegieter, Menno V. Huisman
Publikováno v:
Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety, 30(8), 1027-1036. WILEY
Pharmacoepidemiology and Drug Safety, 30(8), 1027-1036. WILEY
Background Adherence to direct oral anticoagulants (DOACs) in patients with atrial fibrillation in every day practice may be less than in clinical trials. Aims To assess adherence to DOACs in atrial fibrillation patients in every day practice and ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e60e1b59a8ad6d5b5eed5bae231528d8
https://pubmed.ncbi.nlm.nih.gov/33822401
https://pubmed.ncbi.nlm.nih.gov/33822401